Why the study?
Does an invasive strategy after fibrinolytic therapy provide similar outcomes to primary PCI in STEMI patients?
Does an invasive strategy after fibrinolytic therapy provide similar outcomes to primary PCI in STEMI patients?
This review highlights that a pharmacoinvasive strategy can yield similar outcomes to primary PCI in STEMI patients, particularly when system delays prevent timely primary PCI.
Answers are grounded in this paper and cite their sources.
May inform pharmacoinvasive decisions when primary PCI is delayed; leaves open need for prospective RCTs.
Recently, primary percutaneous coronary intervention (PCI) is the best option for reperfusion in STEMI patients, in clinical trials has lower rates of reinfarction, stroke and mortality than fibrinolytic therapy. Because of system delays in routine practice, prehospital administration of fibrinolytic therapy may lead to similar clinical outcomes, especially in those patients who present in early onset after symptom. Assessment of failed reperfu-sion for rescue PCI and invasive strategy after fibrinolitic therapy leading similar outcome with primary PCI. This review focuses on the timing of, and indications for, an invasive strategy after fibrinolytic therapy, including that for failed pharmacological reperfusion.
No takes yet. Share an insight, caveat, or question.
Isman Firdaus (2013) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: